Prosecution Insights
Last updated: July 17, 2026

Dann, Dorfman, Herrell & Skillman

28 pending office actions • 21 clients • 28 examiners • 26 art units • 0 of 28 (0%) have an AI response strategy ready • 48 patents granted in the last 365 days

Quality Metrics (n=4385 apps, methodology: how we score firms)

76.2%
Allowance Rate
n=4385
+0.54σ
Allowance Rate (norm)
n=4385
3.5
OAs to Allowance
n=2471
-0.06σ
OAs to Allow (norm)
n=2471
1156 days
Time to Allowance
n=2471
+15.6pp
Interview Lift
n=4385
20.5%
RCE Rate
n=4385
1.3%
Appeal Rate
n=4385

Rejection Performance (% of received rejections ultimately overcome)

88.4%
§101 Overcome
n=69
85.6%
§102 Overcome
n=355
81.7%
§103 Overcome
n=1331
92.4%
§112 Overcome
n=410

Specialization & Scale

A61K, A61P, C12N
Top CPC Subclasses
21%
Top-3 CPC Share
n=4385
0
Practitioners
n=4385
Apps / Practitioner
n=4385 (min 20)

Portfolio Summary

28
Total Pending OAs
14
Non-Final OAs
14
Final Rejections
0
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 21 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

9
Overdue
0
Due this week
4
Due this month
4
Due in next 60 days
4
Due later

Deadline Fire Line

Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 21 of the docket's apps have a known mailing date.

-30dToday30d60d90d120d
Overdue (9)Due ≤ 30 days (4)Due ≤ 60 days (4)Due later (4)

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

0
Hard (0%)
22
Medium (79%)
4
Easy (14%)
2
Unknown (7%)

Rejection Statute Mix

BucketCases
§103 only20 (71%)
§102 only2 (7%)
§112 only4 (14%)
No statute on record2 (7%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

17
Life Sciences
61% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
2
Semiconductors
7% of docket
8
Mechanical / Eng
29% of docket
1
Business / Other
4% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

280 h
Manual time on pending OAs
56 h
Time saved (low, 20%)
98 h
Time saved (mid, 35%)
2.5 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
FIORELLO, BENJAMIN F 1 73.9% +7.3%
LIANG, ANTHONY M 1 83.4% +9.7%
WONG, TINA MEI SENG 1 84.3% +14.3%
HELM, CARALYNNE E 1 28.8% +49.6%
RAYMOND, LINNAE ELIZABETH 1 50.5% +58.6%
HARRIS, WESLEY G 1 73.5% +21.5%
JAUHARI, SACHI 1 100.0% +0.0%
FONSECA, JESSIE T 1 68.0% +18.8%
PANDE, ASHUTOSH 1 60.0% -11.1%
SHIN, DANA H 1 27.1% +27.5%

Quick Wins (3)

Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 3 ordered by deadline are shown.

App #TitleExaminerDue in
18802192 High Strength, High Impact Toughness Steel Alloy, an Article of Manufacture Made Therefrom, and a Method of Making the Same LIANG, ANTHONY M
18833167 AN APPARATUS WONG, TINA MEI SENG
18278865 Antimicrobial Peptides JAUHARI, SACHI

Hard Cases (2)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.

App #TitleExaminerDue in
18607759 MODULATION OF SOLUBILITY, PALATABILITY, ABSORPTION, AND BIOAVAILABILITY OF MITRAGYNA SPECIOSA-DERIVED COMPOUNDS FOR ORAL AND BUCCAL DELIVERY HELM, CARALYNNE E 38d overdue
18033627 COMPOSITIONS AND METHODS FOR IN VIVO GENE TRANSFER SHIN, DANA H 37d overdue

Interview Candidates (6)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 6 ordered by deadline are shown.

App #TitleExaminerDue in
18607759 MODULATION OF SOLUBILITY, PALATABILITY, ABSORPTION, AND BIOAVAILABILITY OF MITRAGYNA SPECIOSA-DERIVED COMPOUNDS FOR ORAL AND BUCCAL DELIVERY HELM, CARALYNNE E 38d overdue
18033627 COMPOSITIONS AND METHODS FOR IN VIVO GENE TRANSFER SHIN, DANA H 37d overdue
18598171 DEVICES FOR USE WITH SURGICALLY CREATED ORIFICES RAYMOND, LINNAE ELIZABETH 2d overdue
18556371 IMPROVED FEEDING CATHETER HARRIS, WESLEY G 14d
18263391 IMPROVED ROLL-FORMED STRUCTURAL MEMBER FONSECA, JESSIE T 69d
18833167 AN APPARATUS WONG, TINA MEI SENG

Client Portfolio (21 clients)

Top Art Units

Art UnitApps
16372
36781
17341
16151
37811
37831
16541
36331
36681
16351

Pending Office Actions

App #TitleClientExaminerArt UnitStatutesStatusDue inAIFiled
18856824 Tunnel Lining Method and Apparatus Colin Eddie Consulting Limited FIORELLO, BENJAMIN F 3678 §103 Non-Final OA 57d Pending Oct 14, 2024
18802192 High Strength, High Impact Toughness Steel Alloy, an Article of Manufacture Made Therefrom, and a Method of Making the Same Crs Holdings, LLC LIANG, ANTHONY M 1734 §103 Non-Final OA Pending Aug 13, 2024
18833167 AN APPARATUS Duality Quantum Photonics Ltd. WONG, TINA MEI SENG §112 Non-Final OA Pending Jul 25, 2024
18607759 MODULATION OF SOLUBILITY, PALATABILITY, ABSORPTION, AND BIOAVAILABILITY OF MITRAGYNA SPECIOSA-DERIVED COMPOUNDS FOR ORAL AND BUCCAL DELIVERY Syncotrance, LLC HELM, CARALYNNE E 1615 §103 Final Rejection 38d overdue Pending Mar 18, 2024
18598171 DEVICES FOR USE WITH SURGICALLY CREATED ORIFICES The Insides Company Limited RAYMOND, LINNAE ELIZABETH 3781 §103 Non-Final OA 2d overdue Pending Mar 07, 2024
18556371 IMPROVED FEEDING CATHETER The Insides Company Limited HARRIS, WESLEY G 3783 §103 Non-Final OA 14d Pending Oct 20, 2023
18278865 Antimicrobial Peptides BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA JAUHARI, SACHI 1654 §103 Non-Final OA Pending Aug 25, 2023
18263391 IMPROVED ROLL-FORMED STRUCTURAL MEMBER Formsteel Technologies Limited FONSECA, JESSIE T 3633 §112 Final Rejection 69d Pending Jul 28, 2023
18253121 Marine Vessel Fender and Control System C W F Hamilton & Co. Limited PANDE, ASHUTOSH 3668 §103 Final Rejection Pending May 16, 2023
18033627 COMPOSITIONS AND METHODS FOR IN VIVO GENE TRANSFER The Children's Hospital of Philadelphia SHIN, DANA H 1635 §102 Non-Final OA 37d overdue Pending Apr 25, 2023
18194664 NANOFIBER COLLECTION DEVICES BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA VARGOT, MATHIEU D 1742 §103 Non-Final OA 43d Pending Apr 03, 2023
18246572 COMPOSITIONS AND METHODS FOR THE TREATMENT OF HAIR LOSS AND OTHER CONDITIONS Protransit Nanotherapy LLC VARADARAJ, ARCHANA 1658 Other Final Rejection 4d overdue Pending Mar 24, 2023
18016025 SECURE, AUTOMATED, SYSTEM AND COMPUTER IMPLEMENTED PROCESS FOR MONITORING CARE PROVIDED TO A CONSUMER ACCORDING TO A PHARMACOLOGICAL OR NUTRITIONAL REGIMEN OF THE CONSUMER Blunergy S.A. PORTER, RACHEL L 3684 §112 Non-Final OA 28d Pending Jan 13, 2023
18015800 COMPOSITIONS AND METHODS FOR HEMOGLOBIN PRODUCTION The Trustees of the University of Pennsylvania VANHORN, ABIGAIL LOUISE 1636 §103 Final Rejection 69d Pending Jan 12, 2023
18008422 USE OF RECOMBINANT HUMAN ACID SPHINGOMYELINASE TO IMPROVE SKELETAL MYOFIBER REPAIR Children'S National Medical Center HILL, KEVIN KAI 1638 §103 Final Rejection 28d Pending Dec 05, 2022
17918024 MULTI-LAYER HERNIA MESHES AND METHODS OF MANUFACTURE AND USE THEREOF BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA REDDY, SUNITA 3791 §103 Final Rejection Pending Oct 10, 2022
17938857 Compositions and Methods for Treating Huntington's Disease and Related Disorders The Children's Hospital of Philadelphia GOMEZ RODRIGUEZ, JULIO WASHINGTON 1637 §102 Final Rejection 40d Pending Oct 07, 2022
17800793 ELECTROCHROMIC DEVICE AND METHOD FOR PRODUCING THE SAME Freshape SA KING, GEORGE G 2872 §103 Non-Final OA 47d Pending Aug 18, 2022
17786147 COMPOSITIONS AND METHODS FOR HEMOGLOBIN PRODUCTION The Trustees of the University of Pennsylvania PERSONS, JENNA L 1637 §103 Final Rejection 16d overdue Pending Jun 16, 2022
17783365 HIGH-THROUGHPUT DETECTION METHOD FOR RARE MUTATION OF GENE Suzhou Smk Gene Tech Ltd. TURPIN, ZACHARY MARK 1682 §103 Final Rejection 49d overdue Pending Jun 08, 2022
17760570 Doubly Rotated Quartz Crystal Resonators With Reduced Sensitivity to Acceleration Michael Shawn Micilroy ROSENAU, DEREK JOHN 2837 §103 Non-Final OA 11d overdue Pending Mar 15, 2022
17621927 COMPOSITIONS AND METHODS FOR ENHANCING PLANT GROWTH BOYCE THOMPSON INSTITUTE FOR PLANT RESEARCH, INC. PALLAY, MICHAEL B 1617 §103 Final Rejection Pending Dec 22, 2021
17544007 METHODS AND COMPOSITIONS FOR DIAGNOSING NEURODEGENERATIVE DISEASE Board Of The Regents Of The University Of Nebraska CHERNYSHEV, OLGA N 1675 Other Final Rejection 30d overdue Pending Dec 07, 2021
17532123 COMPOSITIONS AND METHODS FOR HEMOGLOBIN PRODUCTION Cold Spring Harbor Laboratory IANNUZO, NATALIE NMN 1653 §103 Non-Final OA Pending Nov 22, 2021
17461413 REAL-TIME RAIL WEAR AND DEFECT MONITORING SYSTEM EMPLOYING DISTANCE MEASURING DEVICES Avante International Technology, Inc. RICHTER, KARA MARIE 3645 §103 Final Rejection 69d Pending Aug 30, 2021
16972727 METHOD FOR PREPARING COMPOSITION COMPRISING KILLED OR INACTIVATED METHANOBREVIBACTER ARCHAEBACTERIA CELLS AND COMPOSITION THEREBY OBTAINED Duncan-Bruce Sutherland ALAM, AYAAN A 1611 §103 Final Rejection 70d Pending Dec 07, 2020
17048702 MEDICAL USES Xnk Therapeutics AB GONZALES, JOSEPHINE MARIA 1631 §103 Non-Final OA 27d Pending Oct 19, 2020
16483548 COMPOSITIONS AND METHODS FOR THE TREATMENT OF PERIPHERAL ARTERY DISEASE BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA LEE, ANDREW P 1691 §112 Non-Final OA 66d overdue Pending Aug 05, 2019

Managing Dann, Dorfman, Herrell & Skillman's Patent Prosecution?

IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month